Syntax Bio expands Series A to $14.4M to boost CRISPR Cellgorithm platform and type 1 diabetes beta-cell therapy amid tough biotech funding—read more.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...

Verizon is giving customers cash-back rewards through a new loyalty program. It's also launching simpler phone plans starting ...

Panther is the third cybersecurity startup that the company has acquired since the start of the year. Databricks previously ...

Python’s lead narrows again, C holds the runner-up spot, C++ returns to third, and SQL climbs back above R in June’s top 10 ...

MANILA, Philippines — The Department of Education (DepEd) will allocate P9 billion for the implementation of the Academic Recovery and Accessible Learning (ARAL) Program in all public basic education ...

The Science Advances publication details Cellgorithm™, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...

Functional programming, as the name implies, is about functions. While functions are part of just about every programming paradigm, including JavaScript, a functional programmer has unique ...